Corbus Pharmaceuticals Holdings Inc. Stock Sheds 4.2%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. slid 4.2% to $7.14 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.5% to 27,068.72 and the Dow Jones Industrial Average rising 0.9% to 51,828.62.

This was the stock's third consecutive day of losses.

Corbus Pharmaceuticals Holdings Inc. closed 65.3% short of its 52-week high of $20.56, which the company reached on October 20th.

The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. rose 1.4% to $5.05, Fortress Biotech Inc. remained unchanged, and Viking Therapeutics Inc. fell 3.24% to $35.56.

Trading volume totaled 686,852, compared to the 50-day average of 771,772.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 25, 2026 16:34 ET (20:34 GMT)